159 related articles for article (PubMed ID: 7855794)
21. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
[TBL] [Abstract][Full Text] [Related]
22. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
23. Pentasaccharide and Orgaran arrest, whereas heparin delays thrombus formation in a rat arteriovenous shunt.
Vogel GM; van Amsterdam RG; Kop WJ; Meuleman DG
Thromb Haemost; 1993 Jan; 69(1):29-34. PubMed ID: 8446935
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotection by recombinant thrombomodulin.
Taoka Y; Okajima K; Uchiba M; Johno M
Thromb Haemost; 2000 Mar; 83(3):462-8. PubMed ID: 10744154
[TBL] [Abstract][Full Text] [Related]
25. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
Fonseca RJ; Mourão PA
Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
[TBL] [Abstract][Full Text] [Related]
26. [Antithrombotic properties of heparin independent of its anticoagulant activity].
Krupiński K; Bielawiec M; Breddin HK
Acta Haematol Pol; 1994; 25(3):243-51. PubMed ID: 7992597
[TBL] [Abstract][Full Text] [Related]
27. Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor.
Calnek DS; Grinnell BW
Exp Cell Res; 1998 Jan; 238(1):294-8. PubMed ID: 9457083
[TBL] [Abstract][Full Text] [Related]
28. [Inhibitory effect of activated protein C and heparin on arterial thrombosis].
Araki H
Nihon Rinsho; 1992 Feb; 50(2):408-12. PubMed ID: 1613999
[TBL] [Abstract][Full Text] [Related]
29. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo.
Takahashi Y; Hosaka Y; Niina H; Nagasawa K; Naotsuka M; Sakai K; Uemura A
Thromb Haemost; 1995 May; 73(5):805-11. PubMed ID: 7482407
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic effect of a novel protein from Fusarium sp. CPCC 480097 in a rat model of artery-vein bypass thrombosis.
Wu B; Xu J
Pharm Biol; 2012 Jul; 50(7):866-70. PubMed ID: 22480350
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: thrombomodulin associates with free thrombin and is recycled to activate protein c.
Aritomi M; Watanabe N; Ohishi R; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):418-22. PubMed ID: 8259541
[TBL] [Abstract][Full Text] [Related]
32. Induction of pulmonary thromboembolism by neutrophil elastase in collagen-induced arthritis mice and effect of recombinant human soluble thrombomodulin.
Matsuoka T; Jin E; Tachihara A; Ghazizadeh M; Nakajima A; Yoshino S; Katayama Y; Kawanami O
Pathobiology; 2008; 75(5):295-305. PubMed ID: 18931532
[TBL] [Abstract][Full Text] [Related]
33. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats].
Xu HL; Feng YP
Yao Xue Xue Bao; 2001 May; 36(5):329-33. PubMed ID: 12584852
[TBL] [Abstract][Full Text] [Related]
34. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect.
Bouton MC; Venisse L; Richard B; Pouzet C; Arocas V; Jandrot-Perrus M
Circ Res; 2007 Apr; 100(8):1174-81. PubMed ID: 17379830
[TBL] [Abstract][Full Text] [Related]
35. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
36. Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor.
Mendes-Silva W; Assafim M; Ruta B; Monteiro RQ; Guimarães JA; Zingali RB
Thromb Res; 2003; 112(1-2):93-8. PubMed ID: 15013279
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of microarterial thrombosis by activated protein C in a rabbit model.
Arnljots B; Bergqvist D; Dahlbäck B
Thromb Haemost; 1994 Sep; 72(3):415-20. PubMed ID: 7855793
[TBL] [Abstract][Full Text] [Related]
38. Evidence of human thrombomodulin domain as a novel angiogenic factor.
Shi CS; Shi GY; Chang YS; Han HS; Kuo CH; Liu C; Huang HC; Chang YJ; Chen PS; Wu HL
Circulation; 2005 Apr; 111(13):1627-36. PubMed ID: 15795324
[TBL] [Abstract][Full Text] [Related]
39. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS
Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic evaluation of recombinant thrombomodulin].
Maruyama I
Nihon Rinsho; 1992 Oct; 50(10):2561-7. PubMed ID: 1333021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
